Facilitated By

San Antonio Medical Foundation

Advanced Development of Multivalent Filovirus (Ebola and Marburg) Hemorrhagic Fever Vaccine

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Patterson, Jean L.
Funded by
Crucell Holland B.V.
Research Start Date
Status
Active

TxBiomed is helping to develop a safe and effective Ebola/Marburg combination vaccine based on recombinant adenoviral vectors to induce protective immunity.

Basic Research
Infectious Disease